Recent FDA action (through September 2008) related to Immediate-release diclofenac capsules, tocilizumab, sugammadex, topical alprostadil cream, fospropofol, iloperidone, lacosamide, and vascular endothelial growth factor b.

Approvable designations

Recommended for approval

Nonapprovable designations

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

FDA Pipeline preview, September 2008

Newsletter